Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

US Ambassador to Israel Calls Hadassah ”A Shining Example of American-Israeli Cooperation”


US Ambassador to Israel Daniel Shapiro (left) with Prof. Ehud Kokia, HadassahUniversity Medical Center Director General

"We look at Hadassah as the premier medical institution in Israel and a shining example of American-Israeli cooperation," U.S. Ambassador to Israel Daniel Shapiro said while visiting the Hadassah University Medical Center at the end of January.

During his visit, the Ambassador toured Hadassah's Department of Pediatric Hemato-Oncology, where he spoke with the young patients, including 13-year-old Orr from Jerusalem and 18-year-old Ismail from Gaza.

Ambassador Shapiro was accompanied by his wife, Julie Fisher, and her mother, Jane Fisher of Minnesota and Florida. Jane is a past president of the Duluth, Minnesota Chapter of Hadassah. They are pictured here in one of the patient rooms of the Sarah Westman Davidson Hospital Tower, scheduled to receive its first patients in mid-March.

Jane recently gifted the Ambassador with a Hadassah Associate membership.


Ambassador Shapiro (right) visiting with Orr from Jerusalem along with Prof Ehud Kokia.

The Ambassador with Ismail and his father, Ibrihim.

Barbara Goldstein, Deputy Director of the Hadassah Office in Israel,pinned Ambassador Shapiro with his Hadassah Associatespin and presented him with a framed certificate signifyinghis new Associate status in Hadassah, while Barbara Sofer,Israel Director of Pubic Relations for Hadassah, and Prof. Kokia look on.

Flanked by his wife, Julie Fisher, and Prof. Kokia, Ambassador Shapiro displays the replicas of ancient medical instruments presented to him as a memento of his visit to Hadassah.
Date: 2/15/2012


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America